New Tiaoxin Recipe Alleviates Energy Metabolism Disorders in an APPswe/PS1DE9 Mouse Model of Alzheimer's Disease

被引:0
|
作者
Hu, Yiran [1 ]
Xing, Sanli [2 ]
Huang, Yan [2 ]
Chen, Chuan [2 ]
Shen, Dingzhu [2 ]
Chen, Jiulin [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 200031, Peoples R China
[2] Shanghai Geriatr Inst Chinese Med, Shanghai 200031, Peoples R China
关键词
Alzheimer's disease; energy dysmetabolism; new tiaoxin recipe; NAD plus; CD38; neurodegenerative disease; QUANTUM SPEEDUP;
D O I
10.2174/1386207326666230428112358
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Alzheimer's disease (AD) is a typical neurodegenerative disease with a complex etiology. Until now, there has been no effective treatment available for AD; however, improving energy dysmetabolism, the key pathological event in the early stage of AD, can effectively delay the progression of AD.Objective: This paper aims to investigate the therapeutic effect and potential mechanism of the new Tiaoxin recipe on early AD.Methods: APP/PS1 mice were divided into a model group, a new Tiaoxin recipe group, and a donepezil group, and C57/BL mice were used for the control group. Mouse cognitive and learning abilities were tested using the Morris water maze test and a new object-recognition experiment. The 42 amino acid form of amyloid beta peptide (A beta 1-42) content was detected by enzyme-linked immunosorbent assay, the senile plaque area was detected by thioflavin S staining, and the senescence-associated beta-galactosidase (SA-beta-gal)-positive area was detected by chemical staining. Also, the adenosine triphosphate (ATP), nicotinamide adenine dinucleotide (NAD+), and nicotinamide adenine dinucleotide hydride (NADH) contents were detected using a biochemical method, and the cluster of differentiation 38 (CD38) and silent mating-type information regulation 2 homolog 3 (SIRT3) protein expression levels were detected by immunofluorescence and Western blot analysis.Results: Compared with those of the control group, the learning and memory abilities of the model group were impaired; the senile plaque deposition, A beta 1-42 content, and SA-beta gal-positive staining area were increased; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were decreased; the CD38 protein expression level was increased; and the SIRT3 protein expression level was decreased. Following intervention with the new Tiaoxin recipe, the learning and memory abilities were improved; the senile plaque deposition, A beta 1-42 content, and SA-beta gal-positive area were reduced; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were increased; CD38 protein expression was decreased, and SIRT3 protein expression was increased.Conclusion: This study shows that the new Tiaoxin Recipe can improve cognitive ability and reduce the A beta 1-42 content and senile plaque deposition in APP/PS1 mice, which may occur through the downregulation of CD38 protein expression, upregulation of SIRT3 protein expression, restoration of the NAD+ level, promotion of ATP synthesis, mitigation of energy metabolism disorders.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 50 条
  • [31] Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology
    Reale, Marcella
    D'Angelo, Chiara
    Costantini, Erica
    Di Nicola, Marta
    Yarla, Nagnedra Sastry
    Kamal, Mohammad Amjad
    Salvador, Nieves
    Perry, George
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (01) : 467 - 476
  • [32] Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer's Disease Mouse Model
    Nasri, Wan Nurzulaikha Wan
    Makpol, Suzana
    Mazlan, Musalmah
    Tooyama, Ikuo
    Ngah, Wan Zurinah Wan
    Damanhuri, Hanafi Ahmad
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 70 : S239 - S254
  • [33] Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease
    Kelly, Patricia
    Denver, Paul
    Satchell, Simon C.
    Ackermann, Maximilian
    Konerding, Moritz A.
    Mitchell, Christopher A.
    ANGIOGENESIS, 2017, 20 (04) : 567 - 580
  • [34] Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
    Zhang, Wei
    Hao, Jian
    Liu, Rui
    Zhang, Zhuo
    Lei, Gesheng
    Su, Changjun
    Mia, Jianting
    Li, Zhuyi
    BEHAVIOURAL BRAIN RESEARCH, 2011, 222 (02) : 342 - 350
  • [35] Early detection of redox imbalance in the APPswe/PS1dE9 mouse model of Alzheimer's disease by in vivo electron paramagnetic resonance imaging
    Emoto, Miho C.
    Sato-Akaba, Hideo
    Hamaue, Naoya
    Kawanishi, Katsuya
    Koshino, Hisashi
    Shimohama, Shun
    Fujii, Hirotada G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 172 : 9 - 18
  • [36] Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model
    Wirz, Kerstin T. S.
    Bossers, Koen
    Stargardt, Anita
    Kamphuis, Willem
    Swaab, Dick F.
    Hol, Elly M.
    Verhaagen, Joost
    NEUROBIOLOGY OF AGING, 2013, 34 (05) : 1328 - 1342
  • [37] APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease
    Lysikova, E. A.
    Kuzubova, E. V.
    Radchenko, A. I.
    Patrakhanov, E. A.
    Chaprov, K. D.
    Korokin, M. V.
    Deykin, A. V.
    Gudyrev, O. S.
    Pokrovskii, M. V.
    MOLECULAR BIOLOGY, 2023, 57 (01) : 74 - 82
  • [38] Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease
    Zhou, Li
    Liu, Jianxu
    Dong, Dong
    Wei, Chunsheng
    Wang, Rui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (01): : 184 - 196
  • [39] Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer's disease
    Agostini, Alessandra
    Ding Yuchun
    Bai Li
    Kendall, David A.
    Pardon, Marie-Christine
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 83 : 87 - 111
  • [40] New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
    Sanchez-Lopez, Elena
    Ettcheto, Miren
    Antonia Egea, Maria
    Espina, Marta
    Cristina Calpena, Ana
    Folch, Jaume
    Camins, Antoni
    Luisa Garcia, Maria
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (03) : 1171 - 1182